BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Sep. 7, 2022

View Archived Issues
IVF

AI embryo analysis reduces the time to pregnancy by 12%

For the one in eight couples struggling to conceive, the improvements in infertility treatments achieved by employment of artificial intelligence (AI) in diagnostics, personalized therapies and embryo selection may soon mean the difference between childlessness and the family of their dreams. Read More
Phillips Recall Mask BiPAP CPAP

Nightmare continues for Philips with recall issued for additional 17M masks

For a company that dominates the market for devices designed to improve breathing during sleep, Royal Philips NV has had the devil of time catching its own breath over the last 15 months as it has issued wave after wave of recalls. Read More
DNA-NGS-genome-sequencing.png

Sectra adding genomics to its medical diagnostics business

Genomics is moving out of the research lab to become a routine element of health care, particularly in oncology to detect gene variants that indicate a patient will respond to a targeted cancer drug, and in the diagnosis of rare diseases. Read More
cancer lens

Smart contact lens detects cancer using tears

Researchers from the Terasaki Institute for Biomedical Innovation (TIBI) in Los Angeles are developing a contact lens that can capture and detect exosomes. These are nanometer-sized vesicles found in bodily secretions which have the potential to be diagnostic cancer biomarkers. The team published its work and findings in August 2022 in Advanced Functional Materials. Read More
pancreas-insulin-diabetic.png

Insulin resistance promotes cognitive impairment in diabetes

Communication between adipose tissue and the brain increases the risk of cognitive impairment in patients with insulin resistance through extracellular vesicles (EVs) containing microRNAs (miRNAs). Neurons could be damaged when these nucleotides reach the hippocampus guided by membrane proteins in prediabetic overweight people. Read More

Appointments and advancements for Sept. 7, 2022

New hires and promotions in the med-tech industry, including: Checkpoint Surgical, Conformal Medical, Glucomodicum, Lynxdx, Miach Orthopaedics, Oncolytics Biotech, Rockwell Medical. Read More

Financings for Sept. 7, 2022

Med-tech firms raising money in public or private financings, including: Bioaffinity Technologies, Guided Therapeutics, Otolith Labs. Read More

In the clinic for Sept. 7, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Electrocore, Premia Spine, Vektor Medical. Read More

Other news to note for Sept. 7, 2022

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuray, Aevis Victoria, Apollo Neuroscience, Basecamp Vascular, BCV, Diadem, Oncocyte, Tearlab, Trukera, Voxneuro, Zoll Medical. Read More

Regulatory actions for Sept. 7, 2022

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Serpex Medical, Viewray. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • EU flag vector

    European Commission floats multiple fixes for MDR, IVDR

    BioWorld MedTech
    The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing